巴多昔芬甲酯用于2型糖尿病和晚期慢性肾病的研究 - Suppr

Suppr

超能文献

Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.

作者信息

Molnár Gergo A, Kovács Tibor, Wittmann István

出版信息

N Engl J Med. 2014 May 1;370(18):1767-8. doi: 10.1056/NEJMc1400872.

DOI:10.1056/NEJMc1400872

PMID:24785222

Abstract

摘要

相似文献

Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.

N Engl J Med. 2014 May 1;370(18):1767-8. doi: 10.1056/NEJMc1400872.

Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.

N Engl J Med. 2014 May 1;370(18):1768-9. doi: 10.1056/NEJMc1400872.

Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.

N Engl J Med. 2014 May 1;370(18):1768. doi: 10.1056/NEJMc1400872.

Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.

N Engl J Med. 2014 May 1;370(18):1767. doi: 10.1056/NEJMc1400872.

Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.

N Engl J Med. 2014 May 1;370(18):1768. doi: 10.1056/NEJMc1400872.

The paradox created by commenting on large clinical trial results.

Diabetes Obes Metab. 2015 Jan;17(1):1-2. doi: 10.1111/dom.12392.

New therapies for diabetic kidney disease.

N Engl J Med. 2013 Dec 26;369(26):2549-50. doi: 10.1056/NEJMe1313104. Epub 2013 Nov 9.

Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.

N Engl J Med. 2013 Dec 26;369(26):2492-503. doi: 10.1056/NEJMoa1306033. Epub 2013 Nov 9.

The paradox of bardoxolone methyl: a call for every witness on the stand?

Diabetes Obes Metab. 2015 Jan;17(1):9-14. doi: 10.1111/dom.12356. Epub 2014 Aug 4.

Baseline characteristics in the Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes mellitus: the Occurrence of renal eveNts (BEACON) trial.

Nephrol Dial Transplant. 2013 Nov;28(11):2841-50. doi: 10.1093/ndt/gft445.

引用本文的文献

Oxidative Stress and Renal Fibrosis: Recent Insights for the Development of Novel Therapeutic Strategies.

Front Physiol. 2018 Feb 16;9:105. doi: 10.3389/fphys.2018.00105. eCollection 2018.

Nrf2 at the heart of oxidative stress and cardiac protection.

Physiol Genomics. 2018 Feb 1;50(2):77-97. doi: 10.1152/physiolgenomics.00041.2017. Epub 2017 Nov 29.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.

N Engl J Med. 2014 May 1;370(18):1767-8. doi: 10.1056/NEJMc1400872.

Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.

N Engl J Med. 2014 May 1;370(18):1768-9. doi: 10.1056/NEJMc1400872.

Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.

N Engl J Med. 2014 May 1;370(18):1768. doi: 10.1056/NEJMc1400872.

Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.

N Engl J Med. 2014 May 1;370(18):1767. doi: 10.1056/NEJMc1400872.

Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.

N Engl J Med. 2014 May 1;370(18):1768. doi: 10.1056/NEJMc1400872.

The paradox created by commenting on large clinical trial results.

Diabetes Obes Metab. 2015 Jan;17(1):1-2. doi: 10.1111/dom.12392.

New therapies for diabetic kidney disease.

N Engl J Med. 2013 Dec 26;369(26):2549-50. doi: 10.1056/NEJMe1313104. Epub 2013 Nov 9.

Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.

N Engl J Med. 2013 Dec 26;369(26):2492-503. doi: 10.1056/NEJMoa1306033. Epub 2013 Nov 9.

The paradox of bardoxolone methyl: a call for every witness on the stand?

Diabetes Obes Metab. 2015 Jan;17(1):9-14. doi: 10.1111/dom.12356. Epub 2014 Aug 4.

Baseline characteristics in the Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes mellitus: the Occurrence of renal eveNts (BEACON) trial.

Nephrol Dial Transplant. 2013 Nov;28(11):2841-50. doi: 10.1093/ndt/gft445.

引用本文的文献

Oxidative Stress and Renal Fibrosis: Recent Insights for the Development of Novel Therapeutic Strategies.

Front Physiol. 2018 Feb 16;9:105. doi: 10.3389/fphys.2018.00105. eCollection 2018.

Nrf2 at the heart of oxidative stress and cardiac protection.

Physiol Genomics. 2018 Feb 1;50(2):77-97. doi: 10.1152/physiolgenomics.00041.2017. Epub 2017 Nov 29.